All Curated Mutation Sites in CCHFV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in CCHFV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
L
  
M
  
Gc
  

Keyword: Hemorrhagic Fever, Crimean-38054375
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 38054375 T1045I
Gc
M
Hemorrhagic Fever, Crimean
R
View
2 38054375 A1046V
Gc
M
Hemorrhagic Fever, Crimean
R
View
3 38054375 G1158E
Gc
M
Hemorrhagic Fever, Crimean
R
View
4 38054375 A1451T
Gc
M
Hemorrhagic Fever, Crimean
R
View
5 38054375 H1527Y
Gc
M
Hemorrhagic Fever, Crimean
R
View
6 38054375 M1597I
Gc
M
Hemorrhagic Fever, Crimean
R
View
7 38054375 K1652R
Gc
M
Hemorrhagic Fever, Crimean
R
View
8 38054375 I778T
Gn
M
Hemorrhagic Fever, Crimean
R
View
9 38054375 H195R
NP
S
Hemorrhagic Fever, Crimean
R
View
10 38054375 R15K
NP
S
Hemorrhagic Fever, Crimean
R
View
11 38054375 T124A
NP
S
Hemorrhagic Fever, Crimean
R
View
12 38054375 T124S
NP
S
Hemorrhagic Fever, Crimean
R
View
13 38054375 G125N
NP
S
Hemorrhagic Fever, Crimean
R
View
14 38054375 I246V
NP
S
Hemorrhagic Fever, Crimean
R
View
15 38054375 S301G
NP
S
Hemorrhagic Fever, Crimean
R
View
16 38054375 V436I
NP
S
Hemorrhagic Fever, Crimean
R
View
Contents
Description

The table shows all curated mutation sites of CCHFV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.